A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.
Manoj Maniar, PhD
Advertisement
Manoj Maniar, PhD, is senior director at the formulation and drug delivery group, BioSciences Division, SRI International.
Articles by Manoj Maniar, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5